FendX Technologies Inc. announced that it has entered into a Collaborative Research Agreement dated December 12, 2023 with McMaster University which details the research and development plan to create a protective catheter coating using nanotechnology licensed pursuant to the license agreement dated February 5, 2021, as amended, between the Company and McMaster. The CRA outlines more fully the research and development work to be conducted by McMaster on behalf of FendX as well as a payment schedule for the maximum research funding requirements. The term of the CRA is for 24 months commencing on the effective date of December 1, 2023, unless terminated in accordance with the provisions of the CRA.